Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
THE NEW STANDARD IN TRACE DETECTION
Corporate Overview
Glenn Bolduc
President & CEO
Safe Harbor Statement
During today’s presentation, we will make certain “forward-looking statements” as
that term is defin...
An American Security Innovator
Implant Sciences is proud to be contributing to the
worldwide fight against terrorism
Compa...
About Implant Sciences (IMSC)
Company Confidential 4
Proven provider of explosives & drugs
trace detection equipment
• Our...
The Challenge
More bomb attacks, new targets
• Critical infrastructure
• Public transportation
Changing tactics
• Shoe bom...
Problems with Existing Methods
• Lack of privacy and dignity
• Concerns over radioactive
materials
• Clogged security chec...
Implant Sciences’ Technology
Patented technology
• inCal™ automatic internal calibration
• Non-radioactive IMS analysis
• ...
Implant Sciences’ Vision
Improving science with innovative IP
The non-contact sampling alternative
• Screening with dignit...
Implant Sciences’ Products
Company Confidential
Industry leading design
• No radioactive materials
• Low operating expense...
The New Standard in Trace Detection
Company Confidential 10
Global Presence in Various Applications
Company Confidential 11
Over 2,000 systems sold in
over 50 countries
Strong BRIC P...
Growing Momentum for QS-B220
Jan 2013 TSA Approval for Cargo Screening
Jul 2013 TSA Approval for Passenger and Baggage Scr...
2012 2013 2014 2015 2016
Growing IMSC Market Opportunity
Company Confidential 13
Aviation Security – 46%
Customs & Borders...
Growth Strategy
Expand U.S. market penetration
• Dedicated government sales team in place now
• Negotiate IDIQ with TSA fo...
High Profile Board of Directors/Advisors
Company Confidential 15
Howard Safir (Board Member)
• Former NYC Police Commissio...
Made in USA
Implant Sciences currently
employs 75 direct employees and
an additional 10-20 through
contract manufacturers
...
Thank You
We welcome your questions
and comments
Company Confidential 17
COSD1402
Upcoming SlideShare
Loading in …5
×

Implant Sciences (OTCQB:IMSC) Presentation

1,507 views

Published on

Implant Sciences (OTCQB:IMSC) is the leader in next generation Explosives Trace Detection (ETD), and established counter-terrorism technology that detects and identifies threats from the small amounts left behind after a person handles explosives. Implant Sciences' security solutions are used worldwide for aviation, public transport, customs, air cargo, critical infrastructure, ports/ borders, and emergency response. The Company has thousands of units deployed to over 50 countries, and its trace detectors have been successfully used at the Sochi Olympics, Beijing Olympics, the Universiade Games, and the Special Olympics.

In January 2013, the Company became only the third ETD manufacturer, and the sole American-owned company, to have product approval from the US Transportation Security Administration. With advanced capabilities including superior sensitivity, automatic internal calibration, rapid clear-down, ush button maintenance, and administration of trace detection. Company's handheld QS-H150 and desktop QS-B220 simplify the use, maintenance, and administration of trace detection. www.implantsciences.com

Published in: Investor Relations
  • Be the first to comment

  • Be the first to like this

Implant Sciences (OTCQB:IMSC) Presentation

  1. 1. THE NEW STANDARD IN TRACE DETECTION Corporate Overview Glenn Bolduc President & CEO
  2. 2. Safe Harbor Statement During today’s presentation, we will make certain “forward-looking statements” as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by the Transportation Security Administration or by other U.S. or foreign government and law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; the risks that our markets are subject to technological change and that our success depends on our ability to develop and introduce new products; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including its most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements. Company Confidential 2
  3. 3. An American Security Innovator Implant Sciences is proud to be contributing to the worldwide fight against terrorism Company Confidential 3
  4. 4. About Implant Sciences (IMSC) Company Confidential 4 Proven provider of explosives & drugs trace detection equipment • Our systems detect microscopic amounts left behind after person handles explosives or drugs • Global customer base, large U.S. opportunity • Over 2,000 systems sold in more than 50 countries • Strong cadre of industry veterans • Presence in government and corporate markets Innovator in trace detection technology • Unmatched technology, new product • Strong IP portfolio: 17 patents, 6 pending
  5. 5. The Challenge More bomb attacks, new targets • Critical infrastructure • Public transportation Changing tactics • Shoe bomber • Underwear bomber • Printer cartridge bomb Different types of threats • “Home-grown” terrorism increasing • Smuggling and narco-terrorism Company Confidential 5 New answers are needed to fight the evolving threat
  6. 6. Problems with Existing Methods • Lack of privacy and dignity • Concerns over radioactive materials • Clogged security checkpoints • Operational availability • Growing security costs Company Confidential 6
  7. 7. Implant Sciences’ Technology Patented technology • inCal™ automatic internal calibration • Non-radioactive IMS analysis • Non-contact vortex collector Engineered for the real world • Low maintenance, low TCO • Rapid clear-down • No rest breaks required • Identifies substances by name Company Confidential 7 “[The industry] will develop a non-contact (non- swabbing) sampling approach which eliminates the inconsistencies that plague manual swabbing and allows targets of varied surface types, structures, and materials to be sampled efficiently.” -Homeland Security Research Corporation
  8. 8. Implant Sciences’ Vision Improving science with innovative IP The non-contact sampling alternative • Screening with dignity • Integrated solutions to unclog security checkpoints • Layered security approach Company Confidential 8 Homeland Security Research Corporation states that there is “no competitive explosives and narcotics trace detection modality on the horizon” to compete with today’s trace detection systems.
  9. 9. Implant Sciences’ Products Company Confidential Industry leading design • No radioactive materials • Low operating expense • Rapid detection, fast clear-down • inCalTM fully automatic internal calibration QS-H150 Handheld Explosives Trace Detector • Choice of non-contact or wipe sampling • Flexibility for Risk-Based Screening CONOPS QS-B220 Desktop Explosives & Drugs Trace Detector • Small footprint ideal for crowded checkpoint • Drug detection capability opens new markets 9
  10. 10. The New Standard in Trace Detection Company Confidential 10
  11. 11. Global Presence in Various Applications Company Confidential 11 Over 2,000 systems sold in over 50 countries Strong BRIC Presence Africa, EU, & Mid-East growth Focus on U.S. Penetration
  12. 12. Growing Momentum for QS-B220 Jan 2013 TSA Approval for Cargo Screening Jul 2013 TSA Approval for Passenger and Baggage Screening Sept 2013 STAC Approval for Cargo, Passenger, and Baggage Screening Oct 2013 Added to TSA Qualified Products List for Cargo Screening Oct 2013 Designated as Qualified Anti-Terrorism Technology by DHS Feb 2014 Qualified Testing & Evaluation for TSA Checkpoint complete Currently In final stage of TSA checkpoint qualification – OT&E (field trial) Company Confidential 12 Looking ahead… TSA Checkpoint and Baggage Qualification (expected June 2014)
  13. 13. 2012 2013 2014 2015 2016 Growing IMSC Market Opportunity Company Confidential 13 Aviation Security – 46% Customs & Borders Government Public Events Seaports Rail Education Commercial Military and Police ETD Market Segments Source: IMS Research, and Management Estimates Handheld Systems Desktop Systems Implant Sciences’ Market Opportunity TSA Checkpoint and Baggage Qualification Focus on regulatory approvals grows IMSC opportunity. ACSTL STAC 350% market opportunity growth 2012-2106. PotentialProductRevenue
  14. 14. Growth Strategy Expand U.S. market penetration • Dedicated government sales team in place now • Negotiate IDIQ with TSA for checkpoint and baggage • Leverage QPL status with other agencies Enhance international sales, marketing & distribution • STAC certification opens the European market • QPL with STAC provides greatly expanded global reach • Collaboration opportunity with other security providers IP Leverage • New products, new technologies • Licensing • Development agreements Company Confidential 14
  15. 15. High Profile Board of Directors/Advisors Company Confidential 15 Howard Safir (Board Member) • Former NYC Police Commissioner and Former NYC Fire Commissioner • Assistant Director of the DEA • Chief of the Witness Security Division, U.S. Marshals Service Robert Liscouski (Board Member) • First Assistant Secretary for Infrastructure Protection at DHS • 11 years with the Diplomatic Security Service at the State Department • Director of Information Assurance for The Coca-Cola Company Dr. Bill McGann (COO, Board Member) • Original developer of ETD technology at Ion Track, successfully sold to GE • Chief Technology Officer at GE Homeland Security • Strong TSA/TSL relationships Mo McGowan (Advisor) • One of the founders of the Transportation Security Administration • Assistant Administrator for Security Operations • General Manager for Cargo and Supply Chain Security
  16. 16. Made in USA Implant Sciences currently employs 75 direct employees and an additional 10-20 through contract manufacturers We source 95% of our inputs locally, affecting an additional 50- 75 jobs For every 45 incremental units, we can create another U.S. job Company Confidential 16
  17. 17. Thank You We welcome your questions and comments Company Confidential 17 COSD1402

×